Letter to the Editor: Effect of Pre-transplant Viral Therapy on Post-transplant Hepatitis B Virus Reactivation in Patients with Hepatitis B-related Hepatocellular Carcinoma
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Sundaram V, Kowdley K
. Management of chronic hepatitis B infection. BMJ. 2015; 351:h4263.
DOI: 10.1136/bmj.h4263.
View
2.
Bozza C, Cinausero M, Iacono D, Puglisi F
. Hepatitis B and cancer: A practical guide for the oncologist. Crit Rev Oncol Hematol. 2015; 98:137-46.
DOI: 10.1016/j.critrevonc.2015.10.017.
View
3.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A
. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249.
DOI: 10.3322/caac.21660.
View
4.
Li H, Lu D, Chen J, Zhang J, Zhuo J, Lin Z
. Post-transplant hepatitis B virus reactivation impacts the prognosis of patients with hepatitis B-related hepatocellular carcinoma: a dual-centre retrospective cohort study in China. Int J Surg. 2024; 110(4):2263-2274.
PMC: 11019990.
DOI: 10.1097/JS9.0000000000001141.
View